Literature DB >> 2582106

Clinical presentation of homozygous sickle cell disease.

R Bainbridge, D R Higgs, G H Maude, G R Serjeant.   

Abstract

The pattern of initial clinical symptoms and signs developing in a representative sample of 305 children with homozygous sickle cell (SS) disease diagnosed at birth was analyzed. Specific symptoms were present by age 6 months in 6% of the group, and had developed by the first to eighth birthdays in 32%, 61%, 78%, 86%, 90%, 92%, 94%, and 96%, respectively. Inclusion of nonspecific symptoms in the analysis led to earlier recognition by a mean of 3 months in the first year and by a mean of approximately 1 year between the ages of 2 and 4 years. Dactylitis was the most common initial symptom, noted in 40% of the group overall and in 50% in the first 2 years. Painful crisis was the first symptom in more than one fourth of the patients and was the most frequent symptom after the age of 2 years. Acute splenic sequestration led to presentation in one-fifth of the group overall and in one third of patients younger than 2 years. The most common nonspecific symptom was pneumonia. There was a significant trend of earlier presentation in children with low fetal hemoglobin levels. The age at presentation did not appear to be affected by alpha-thalassemia status.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2582106     DOI: 10.1016/s0022-3476(85)80230-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  10 in total

1.  CE: Understanding the Complications of Sickle Cell Disease.

Authors:  Paula Tanabe; Regena Spratling; Dana Smith; Peyton Grissom; Mary Hulihan
Journal:  Am J Nurs       Date:  2019-06       Impact factor: 2.220

2.  Identifying children with sickle cell anaemia in a non-endemic country: age at diagnosis and presenting symptoms.

Authors:  Xandra van den Tweel; Harriët Heijboer; Karin Fijnvandraat; Marjolein Peters
Journal:  Eur J Pediatr       Date:  2006-04-29       Impact factor: 3.183

Review 3.  Current concerns in haematology. 1. Is the painful crisis of sickle cell disease a "steal" syndrome?

Authors:  G R Serjeant; R M Chalmers
Journal:  J Clin Pathol       Date:  1990-10       Impact factor: 3.411

4.  National trends in the mortality of children with sickle cell disease, 1968 through 1992.

Authors:  H Davis; K C Schoendorf; P J Gergen; R M Moore
Journal:  Am J Public Health       Date:  1997-08       Impact factor: 9.308

5.  Geographic differences in mortality of young children with sickle cell disease in the United States.

Authors:  H Davis; P J Gergen; R M Moore
Journal:  Public Health Rep       Date:  1997 Jan-Feb       Impact factor: 2.792

Review 6.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

7.  How to reach rapid diagnosis in sickle cell disease?

Authors:  Ehsan Valavi; Mohammad Javad Alemzadeh Ansari; Khodamorad Zandian
Journal:  Iran J Pediatr       Date:  2010-03       Impact factor: 0.364

8.  Sickle cell disease: acute clinical manifestations in early childhood and molecular characteristics in a group of children in Rio de Janeiro.

Authors:  Isaac Lima da Silva Filho; Georgina Severo Ribeiro; Patrícia Gomes Moura; Monica Longo Vechi; Andréa Cony Cavalcante; Maria José de Andrada-Serpa
Journal:  Rev Bras Hematol Hemoter       Date:  2012

9.  Kawasaki disease: two case reports from the Aga Khan Hospital, Dar es Salaam-Tanzania.

Authors:  Mariam Noorani; Nuruddin Lakhani
Journal:  BMC Pediatr       Date:  2018-10-23       Impact factor: 2.125

10.  Chronic Kidney Disease amongst Sickle Cell Anaemia Patients at the University of Maiduguri Teaching Hospital, Northeastern Nigeria: A Study of Prevalence and Risk Factors.

Authors:  A A Bukar; M M Sulaiman; A I Ladu; A M Abba; M K Ahmed; G T Marama; U M Abjah
Journal:  Mediterr J Hematol Infect Dis       Date:  2019-01-01       Impact factor: 2.576

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.